Molecular Diagnostics
Blood-Based Screening Test for Colorectal Cancer Demonstrates Strong Clinical Performance
A blood test for the detection of colorectal cancer (CRC) has demonstrated 83% sensitivity with specificity of 90%, paving the way for the first potential US FDA-approved blood test for CRC screening. More...03 Jan 2023
Blood Test Helps Diagnose Inaccessible Brain Tumors
Presently, no blood test is available for diagnosing brain cancers, and doctors have to rely on complex surgical procedures to obtain tumor tissue for histopathological evaluation. Now, a new blood test can detect the cells released from the brain tumor that are extremely rare and hard to detect, enabling early diagnosis and treatment. More...03 Jan 2023
Clinical Microarray System Developed for Genetic Analysis Screening
In precision medicine, preoperative or postoperative genetic testing can be used to stratify patients according to disease states and select appropriate drugs, enabling efficient delivery of personalized treatment. More...02 Jan 2023
First Leukemia Diagnostic Test Based on DNA Sequencing Detects up To 51 Gene Mutations
Until 2022 the only leukemia tests done could detect two gene mutations. Now, a new leukemia diagnostic test is capable of detecting 51 gene mutations, marking a significant technological and medical advancement. More...02 Jan 2023
Biomarker Test Detects Alzheimer’s Neurodegeneration in Blood
Scientists have applied their knowledge of molecular biology and biochemistry of tau proteins in different tissues, such as the brain, to develop a technique to selectively detect “brain-derived tau,” or BD-tau, a novel marker of Alzheimer’s disease neurodegeneration, while avoiding free-floating “big tau” proteins produced by cells outside the brain. More...28 Dec 2022
Tuberculosis Pathogen Dynamics Detected With Nanopore Sequencing
Mycobacterium tuberculosis whole-genome sequencing (WGS) has been widely used for genotypic drug susceptibility testing (DST) and outbreak investigation. For both applications, Illumina technology is used by most public health laboratories. More...26 Dec 2022
Real-Time PCR-Based Serological Diagnosis of Human Granulocytic Anaplasmosis
Human granulocytic anaplasmosis (HGA) is a tick-borne infection caused by the intracellular bacterium Anaplasma phagocytophilum, an emerging pathogen. HGA can manifest as a subclinical infection; however, most symptomatic persons have fever, myalgia, and headache associated with thrombocytopenia, leukopenia, and elevated transaminase levels. More...26 Dec 2022
Gold Member
Quality Control Material
iPLEX Pro Exome QC Panel
Automated Chemiluminescence Immunoassay Analyzer
MS-i3080
Silver Member
PCR Plates
Diamond Shell PCR Plates
In Other News
Blood Test to Separate Bacterial and Viral Infections Could Reduce Antibiotic Overuse
Ultrafast, Ultra-Sensitive Protein Detection Method Enables Ultra-Early Disease Diagnosis
Extremely Sensitive Fluorescence Lateral Flow Reader Detects Even Low Positives Results
Late-Onset Ataxia Linked to Repeat Expansion in FGF14 Gene
POC Assay Could Diagnose Acute Coronary Syndrome in 3-5 Minutes
PCR Test Detects Non-Variola Orthopoxviruses, Including Monkeypox Virus, in 3.5 Hours
POC Molecular TB Test Could Enable Clinicians to Begin Appropriate Treatment Immediately
New Digital Platform Technology Aims to Disrupt 50-Year-Old PCR Testing for Similar-Symptom Pathogens
Lupus Heterogeneity Highlighted With Single-Cell Transcriptomes
PCR-Based CRC Early Detection Stool Test Fills Important Gap Between FIT and Colonoscopy
Early-Pregnancy Urine Test Could Predict Preeclampsia
Portable qPCR Platform Enables Faster, Better, Low-Cost Near-Patient Molecular Diagnosis
Long COVID Etiologies Found in Acute Infection Blood Samples
POCT Immunoassay Reader Provides Quantitative Analysis of Test Kits for More Accurate Diagnosis
World’s First Rapid Saliva-Based Pregnancy Test Eliminates Need for Blood and Urine Samples
Cepheid's Multi-Target Test Design Enables Detection of Influenza Variants
Portable UTI Molecular Diagnostic Platform Provides Accurate Test Results in 40 Minutes
New Blood Test Detects ‘Toxic’ Protein Years Before Alzheimer’s Symptoms Emerge
Biomarkers Predict Lyme Disease Post-Treatment Prognosis
Low Cost, Highly Sensitive Blood Test for Cancer Makes Regular Monitoring Affordable
New All-In-One Molecular Diagnostic System Realizes True Sample In -Result Out Detection Process
Method Enables Targeted Profiling of Human Extrachromosomal DNA
ctDNA-Based MRD Test to Detect As Few As One Mutant Molecule in a Million DNA Molecules
Genetic Testing channel of LabMedica brings the latest in molecular genetics, cytogenetics, and epigenetics, and methods from PCR to FISH, and more.
